DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, J. A.
Right arrow Articles by Diliberto, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, J. A.
Right arrow Articles by Diliberto, J. J.

Vol. 26, Issue 7, 714-719, July 1998

SHORT COMMUNICATION
Effects of Age, Sex, and Pharmacologic Agents on the Biliary Elimination of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in F344 Rats

Joseph A. Jackson, Linda S. Birnbaum, and Janet J. Diliberto

Experimental Toxicology Division,
National Health and Environmental
Effects Research Laboratory,
U. S. Environmental Protection Agency

The extreme biological persistence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due primarily to its resistance to metabolic transformation. Previous studies in several species have found hepatic metabolism to be rate-limiting for TCDD elimination, with resulting metabolites excreted primarily in feces via the bile. Using short-term biliary excretion of [3H]TCDD metabolites as an indirect measure of metabolism, groups of F344 rats were used to evaluate separately the effects of age, sex, and acute induction or inhibition of key hepatic enzymes. Adult and juvenile male and female rats were used for sex comparisons, and senescent male rats were used to explore possible changes in TCDD metabolism with age. Various pretreatments were used: phenobarbital (PB) and dexamethasone (DEX), to induce hepatic cytochrome P450 isozymes; and suicide substrate 1-aminobenzotriazole (ABT), to produce P450 inhibition. For all animals, surgical cannulation of the common bile duct and 6-hr bile collection were performed under constant anesthesia. [3H]TCDD (1 nmol/kg) was administered via the femoral vein. Naive adult male and female rats excreted ~0.7% and ~0.4% of [3H]TCDD-derived radioactivity, respectively. Biliary excretion of radioactivity in both male and female juvenile rats was similar to that of adult males; senescent male rats excreted less. Pretreatment with PB, DEX, or ABT resulted in similar decrease in biliary excretion of TCDD-derived radioactivity as observed in senescent male rats.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
J. J. Diliberto, M. J. DeVito, D. G. Ross, and L. S. Birnbaum
Subchronic Exposure of [3H]-2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Female B6C3F1 Mice: Relationship of Steady-State Levels to Disposition and Metabolism
Toxicol. Sci., June 1, 2001; 61(2): 241 - 255.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. P. Slezak, G. E. Hatch, M. J. DeVito, J. J. Diliberto, R. Slade, K. Crissman, E. Hassoun, and L. S. Birnbaum
Oxidative Stress in Female B6C3F1 Mice following Acute and Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
Toxicol. Sci., April 1, 2000; 54(2): 390 - 398.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.